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Supplementary Figure 1. Differential effects of PMI and SFN on 
mitochondrial ubiquitination 
 
(A) Graph showing p62 mRNA levels in MEFs treated with DMSO vehicle 
control, PMI (10 µM) and/or SFN (1 µM) for 24 h, n =3. (B) Western blot of 
mitochondrial fractions, highlighting mitochondrial ubiquitination following 24 h 
treatments with DMSO vehicle control, PMI (10 µM) and/or SFN (1 µM). β- 
subunit is shown as loading control. (C) Graph showr Ub:β-subunit ratio band 
density analysis (n=3, *p < 0.05). All values are mean ± SD. 
 
Supplementary Figure 2. Knockout of Keap1 is sufficient to increase 
mitochondrial superoxide production and induce mitophagy. 
 
(A) Representative high resolution images of LC3 localisation in WT and KEAP1 KO 
MEF cells, treated with DMSO vehicle control or 10 µM PMI for 24 h. Cells were 
immunolabeled for LC3 (green) and β-subunit (red). Scale bar represents 10 µm. A 
magnification of the merge images is shown in areas demarcated by the white box. 
(B) Quantification of the extent of LC3:β-subunit co-localization (n > 20, *p < 0.05). 
(C) Quantification of mean mitoSOX fluorescence intensity in WT and KEAP1 KO 
MEF cells, treated with DMSO vehicle control or 10 µM PMI for 24 h (n > 20, ***p < 
0.001). (D) Graph showing absence of alterations in mRNA levels of 5 mitophagy 
receptors in SH-SY5Y cells treated with DMSO vehicle control, 1 µM SFN, or 10 µM 
PMI for 8 h. 
